JP2013543869A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543869A5 JP2013543869A5 JP2013538963A JP2013538963A JP2013543869A5 JP 2013543869 A5 JP2013543869 A5 JP 2013543869A5 JP 2013538963 A JP2013538963 A JP 2013538963A JP 2013538963 A JP2013538963 A JP 2013538963A JP 2013543869 A5 JP2013543869 A5 JP 2013543869A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- composition according
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41377110P | 2010-11-15 | 2010-11-15 | |
| US61/413,771 | 2010-11-15 | ||
| PCT/US2011/060520 WO2012067981A1 (en) | 2010-11-15 | 2011-11-14 | Combination therapy for b cell lymphomas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013543869A JP2013543869A (ja) | 2013-12-09 |
| JP2013543869A5 true JP2013543869A5 (https=) | 2015-01-15 |
Family
ID=46084355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013538963A Pending JP2013543869A (ja) | 2010-11-15 | 2011-11-14 | Ｂ細胞リンパ腫のための併用療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20130330328A1 (https=) |
| EP (1) | EP2640416A4 (https=) |
| JP (1) | JP2013543869A (https=) |
| KR (1) | KR20130130726A (https=) |
| CN (1) | CN103228291A (https=) |
| AU (1) | AU2011329161A1 (https=) |
| CA (1) | CA2817842A1 (https=) |
| MX (1) | MX2013005270A (https=) |
| RU (1) | RU2013127115A (https=) |
| SG (1) | SG190254A1 (https=) |
| WO (1) | WO2012067981A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS62155B1 (sr) * | 2016-05-30 | 2021-08-31 | Morphosys Ag | Postupci predviđanja terapijske koristi anti-cd19 terapije kod pacijenata |
| WO2019011918A1 (en) | 2017-07-10 | 2019-01-17 | International - Drug - Development - Biotech | TREATMENT OF LYMPHOCYTE B MALIGNANCIES USING AFUCOSYLATED PRO-APOPTOTIC ANTI-CD19 ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES OR CHEMOTHERAPEUTIC AGENTS |
| RU2738802C1 (ru) * | 2019-08-21 | 2020-12-17 | Общество с ограниченной ответственностью "Международный Биотехнологический Центр "Генериум" | Определяющие комплементарность участки для связывания cd3 и содержащая их биспецифическая антигенсвязывающая молекула |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101335798B1 (ko) * | 2005-02-15 | 2013-12-02 | 듀크 유니버시티 | 항-ｃｄ19 항체 및 종양학에서 이의 용도 |
| WO2007146968A2 (en) * | 2006-06-12 | 2007-12-21 | Trubion Pharmaceuticals, Inc. | Single-chain multivalent binding proteins with effector function |
| KR101456728B1 (ko) * | 2006-09-08 | 2014-10-31 | 메디뮨 엘엘씨 | 인간화 항-ｃｄ19 항체, 및 이것의 종양학, 이식 및 자가면역 질환의 치료에서의 용도 |
-
2011
- 2011-11-14 AU AU2011329161A patent/AU2011329161A1/en not_active Abandoned
- 2011-11-14 JP JP2013538963A patent/JP2013543869A/ja active Pending
- 2011-11-14 WO PCT/US2011/060520 patent/WO2012067981A1/en not_active Ceased
- 2011-11-14 CN CN2011800548133A patent/CN103228291A/zh active Pending
- 2011-11-14 SG SG2013036512A patent/SG190254A1/en unknown
- 2011-11-14 CA CA2817842A patent/CA2817842A1/en not_active Abandoned
- 2011-11-14 US US13/885,219 patent/US20130330328A1/en not_active Abandoned
- 2011-11-14 MX MX2013005270A patent/MX2013005270A/es unknown
- 2011-11-14 RU RU2013127115/15A patent/RU2013127115A/ru not_active Application Discontinuation
- 2011-11-14 EP EP11841807.8A patent/EP2640416A4/en not_active Withdrawn
- 2011-11-14 KR KR1020137012967A patent/KR20130130726A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528720A5 (https=) | ||
| US20200206228A1 (en) | Combination of an anti-cd19 antibody and a bruton's tyrosine kinase inhibitor and uses thereof | |
| JP2017528462A5 (https=) | ||
| JP2017501157A5 (https=) | ||
| JP2015529225A5 (https=) | ||
| AU2022202800B2 (en) | Combinations and uses thereof | |
| FI3932951T3 (fi) | Menetelmiä ihosyövän hoitamiseksi antamalla PD-1-inhibiittoria | |
| ES2808565T3 (es) | Composiciones que comprenden anticuerpos anti-CD38 y carfilzomib | |
| HRP20231156T1 (hr) | Kombinacija anti-pd-1 antitijela i bispecifičnih anti-cd20/anti-cd3 antitijela za liječenje raka | |
| JP2017507954A5 (https=) | ||
| JP2015532292A5 (https=) | ||
| JP2014533279A5 (https=) | ||
| RU2625222C2 (ru) | Комбинированная терапия антителом к cd19 и азотистым ипритом | |
| EP3532098B1 (en) | Combination of anti cd19 antibody with a bcl-2 inhibitor and uses thereof | |
| HK1251152A1 (en) | Combination of an anti-cd19 antibody and a bruton's tyrosine kinase inhibitor and uses thereof | |
| JP2014525926A5 (https=) | ||
| JP2013543869A5 (https=) | ||
| RU2013127115A (ru) | Комбинированная терапия при в-клеточных лимфомах | |
| HK40023127A (en) | Combination of an anti-cd19 antibody and a bruton's tyrosine kinase inhibitor and uses thereof | |
| HK40014532B (en) | Combination of anti cd19 antibody with a bcl-2 inhibitor and uses thereof | |
| HK40014532A (en) | Combination of anti cd19 antibody with a bcl-2 inhibitor and uses thereof | |
| TW201315461A (zh) | 與放射線治療關聯之包含奧瑞布林（ｏｍｂｒａｂｕｌｉｎ）及西妥昔單抗（ｃｅｔｕｘｉｍａｂ）之抗腫瘤組合 |